Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. 3. Regional distribution of pimozide and of haloperidol in the dog brain - PubMed (original) (raw)
- PMID: 5696000
Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. 3. Regional distribution of pimozide and of haloperidol in the dog brain
P A Janssen et al. Arzneimittelforschung. 1968 Mar.
No abstract available
Similar articles
- Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine.
Janssen PA, Niemegeers CJ, Schellekens KH, Dresse A, Lenaerts FM, Pinchard A, Schaper WK, van Nueten JM, Verbruggen FJ. Janssen PA, et al. Arzneimittelforschung. 1968 Mar;18(3):261-79. Arzneimittelforschung. 1968. PMID: 4386815 No abstract available. - The distribution of the butyrophenones haloperidol, trifluperidol, moperone, and clofluperol in rats, and its relationship with their neuroleptic activity.
Janssen PA, Allewijn FT. Janssen PA, et al. Arzneimittelforschung. 1969 Feb;19(2):199-208. Arzneimittelforschung. 1969. PMID: 5818759 No abstract available. - Clopimozide (R 29 764), a new highly potent and orally long-acting neuroleptic of the diphenylbutylpiperidine series.
Janssen PA, Niemegeers CJ, Schellekens KH, Lenaerts FM, Wauquier A. Janssen PA, et al. Arzneimittelforschung. 1975 Aug;25(8):1287-94. Arzneimittelforschung. 1975. PMID: 1242360 - [Experimental study of delayed-action injectable neuroleptics].
Julou L. Julou L. Actual Pharmacol (Paris). 1972;25:23-59. Actual Pharmacol (Paris). 1972. PMID: 4575937 Review. French. No abstract available.
Cited by
- Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists.
Gould RJ, Murphy KM, Reynolds IJ, Snyder SH. Gould RJ, et al. Proc Natl Acad Sci U S A. 1983 Aug;80(16):5122-5. doi: 10.1073/pnas.80.16.5122. Proc Natl Acad Sci U S A. 1983. PMID: 6136040 Free PMC article. - Pimozide: a review of its pharmacological properties and therapeutic uses in psychiatry.
Pinder RM, Brogden RN, Swayer R, Speight TM, Spencer R, Avery GS. Pinder RM, et al. Drugs. 1976;12(1):1-40. doi: 10.2165/00003495-197612010-00001. Drugs. 1976. PMID: 824116 Review. - Region specific distribution of levomepromazine in the human brain.
Kornhuber J, Weigmann H, Röhrich J, Wiltfang J, Bleich S, Meineke I, Zöchling R, Härtter S, Riederer P, Hiemke C. Kornhuber J, et al. J Neural Transm (Vienna). 2006 Mar;113(3):387-97. doi: 10.1007/s00702-005-0331-3. Epub 2005 Jul 6. J Neural Transm (Vienna). 2006. PMID: 15997416 - Neurometabolic and behavioural effects of haloperidol in relation to drug levels in serum and brain.
Ohman R, Larsson M, Nilsson IM, Engel J, Carlsson A. Ohman R, et al. Naunyn Schmiedebergs Arch Pharmacol. 1977 Sep;299(2):105-14. doi: 10.1007/BF00498552. Naunyn Schmiedebergs Arch Pharmacol. 1977. PMID: 909609 - The distribution of haloperidol in rat brain.
Naylor RJ, Olley JE. Naylor RJ, et al. Br J Pharmacol. 1969 May;36(1):208P-209P. Br J Pharmacol. 1969. PMID: 5768117 Free PMC article. No abstract available.